Effect of Ginseol Kg1 on Blood Pressure Lowering (NCT01483430) | Clinical Trial Compass
UnknownPhase 3
Effect of Ginseol Kg1 on Blood Pressure Lowering
South Korea90 participantsStarted 2011-09
Plain-language summary
In this study, we investigate the effects of Ginseol Kg1 (Korea red ginseng extract) on blood pressure in prehypertensive or stage I hypertensive patients.
Who can participate
Age range20 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: Adults over 20 years
* Prehypertension or stage 1 hypertension (systolic blood pressure 120\~159mmHg or diastolic blood pressure 80\~99mmHg)
* Subject who has not taken medications to treat hypertension within 15 days prior to first visit
Exclusion Criteria:
* Subject who has been involved in other clinical trials within 30 days prior to first visit
* Subject who has following diseases within 2 years prior to screening: angina pectoris, myocardial infarction, heart failure, peripheral vascular disease, chronic liver failure, chronic renal failure, diabetes mellitus, hyperthyroidism, hypothyroidism, malignant tumor, mental disease
* Systolic blood pressure ≥ 160mmHg or diastolic blood pressure ≥ 100 mmHg during screening period
* Subject who has hepatic dysfunction(AST, ALT ≥ 2.5 times higher than normal value)
* Subject who has renal dysfunction(creatinine ≥ 1.5 times higher than normal value)
* Subject who is pregnant or breast feeding
* Alcoholic
* Subject who has an allergy to the ingredients of study product
What they're measuring
1
The difference of the changes in office diastolic and systolic BP after 8 weeks' treatment between placebo and Ginseol Kg1 group